{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:40:16Z","timestamp":1784263216701,"version":"3.55.0"},"reference-count":219,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272769"],"award-info":[{"award-number":["82272769"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972392"],"award-info":[{"award-number":["81972392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejphar.2026.178611","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:21:40Z","timestamp":1769790100000},"page":"178611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Metabolic crosstalk in the metastatic prostate cancer-bone microenvironment: mechanism, detection and therapeutic strategies"],"prefix":"10.1016","volume":"1016","author":[{"given":"Ruoxuan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3681-0411","authenticated-orcid":false,"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejphar.2026.178611_bib1","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00259-013-2489-5","article-title":"PET\/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer","volume":"40","author":"Afshar-Oromieh","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00259-013-2660-z","article-title":"Comparison of PET\/CT and PET\/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience","volume":"41","author":"Afshar-Oromieh","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.urolonc.2011.05.001","article-title":"Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer?","volume":"31","author":"Aggarwal","year":"2013","journal-title":"Urol. Oncol."},{"issue":"9","key":"10.1016\/j.ejphar.2026.178611_bib4","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41416-021-01435-5","article-title":"Metabolic reprogramming in prostate cancer","volume":"125","author":"Ahmad","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.ejphar.2026.178611_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1200771","article-title":"Metabolic reprogramming of myeloid-derived suppressor cells (MDSC) in cancer","volume":"5","author":"Al-Khami","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ejphar.2026.178611_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106775","article-title":"Malignant function of nuclear factor-kappaB axis in prostate cancer: molecular interactions and regulation by non-coding RNAs","volume":"194","author":"Al-Rashidi","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12964-023-01294-y","article-title":"Castration promotes the browning of the prostate tumor microenvironment","volume":"21","author":"Alvarez-Artime","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"13","key":"10.1016\/j.ejphar.2026.178611_bib8","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178611_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-030-65768-0_10","article-title":"Different tumor microenvironments lead to different metabolic phenotypes","volume":"1311","author":"Antonio","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/pros.2990200302","article-title":"Osteocalcin: is it a useful marker of bone metastasis and response to treatment in advanced prostate cancer?","volume":"20","author":"Arai","year":"1992","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.celrep.2019.12.089","article-title":"Human bone marrow is comprised of adipocytes with specific lipid metabolism","volume":"30","author":"Attane","year":"2020","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1158\/0008-5472.CAN-23-0555","article-title":"Adipose triglyceride lipase is a therapeutic target in advanced prostate cancer that promotes metabolic plasticity","volume":"84","author":"Awad","year":"2024","journal-title":"Cancer Res."},{"issue":"14\u201316","key":"10.1016\/j.ejphar.2026.178611_bib13","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1080\/15384101.2023.2229713","article-title":"SRF inhibitors reduce prostate cancer cell proliferation through cell cycle arrest in an isogenic model of castrate-resistant prostate cancer","volume":"22","author":"Azam","year":"2023","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s42255-018-0002-y","article-title":"Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer","volume":"1","author":"Bader","year":"2019","journal-title":"Nat. Metab."},{"issue":"11","key":"10.1016\/j.ejphar.2026.178611_bib15","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.3390\/ijms22115736","article-title":"Hijacked immune cells in the tumor microenvironment: molecular mechanisms of immunosuppression and cues to improve T cell-based immunotherapy of solid tumors","volume":"22","author":"Balta","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178611_bib16","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.3390\/ijms25063142","article-title":"Targeting the Warburg effect in cancer: where do we stand?","volume":"25","author":"Barba","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1200\/JCO.2016.69.1584","article-title":"Randomized, double-blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients with metastatic chemotherapy-naive castration-resistant prostate cancer","volume":"35","author":"Beer","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","article-title":"The metabolism of cancer cells during metastasis","volume":"21","author":"Bergers","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"18","key":"10.1016\/j.ejphar.2026.178611_bib19","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1080\/15384101.2023.2265676","article-title":"Pan-cancer integrated bioinformatic analysis of RNA polymerase subunits reveal RNA Pol I member CD3EAP regulates cell growth by modulating autophagy","volume":"22","author":"Bhandari","year":"2023","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.immuni.2015.09.001","article-title":"Metabolic reprogramming of immune cells in cancer progression","volume":"43","author":"Biswas","year":"2015","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.ejphar.2026.178611_bib21","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/cancers12071887","article-title":"The role of cancer-associated fibroblasts in prostate cancer tumorigenesis","volume":"12","author":"Bonollo","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"17","key":"10.1016\/j.ejphar.2026.178611_bib22","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.4161\/cc.9.17.12731","article-title":"Ketones and lactate \"fuel\" tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism","volume":"9","author":"Bonuccelli","year":"2010","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrendo.2012.201","article-title":"The role of osteocalcin in human glucose metabolism: marker or mediator?","volume":"9","author":"Booth","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib24","first-page":"198","article-title":"The metabolic modulator PGC-1alpha in cancer","volume":"9","author":"Bost","year":"2019","journal-title":"Am. J. Cancer Res."},{"issue":"10","key":"10.1016\/j.ejphar.2026.178611_bib25","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid metabolism in cancer: new perspectives and emerging mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jnci\/dji002","article-title":"Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors","volume":"97","author":"Brown","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.ejphar.2026.178611_bib27","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/bjc.2012.138","article-title":"The differential effects of statins on the metastatic behaviour of prostate cancer","volume":"106","author":"Brown","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ejphar.2026.178611_bib28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.bjc.6603030","article-title":"Promotion of prostatic metastatic migration towards human bone marrow stoma by omega 6 and its inhibition by omega 3 PUFAs","volume":"94","author":"Brown","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bjc.6605481","article-title":"Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer","volume":"102","author":"Brown","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum. Pathol."},{"issue":"Pt 6","key":"10.1016\/j.ejphar.2026.178611_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/000456320203900602","article-title":"Receptor activator for nuclear factor kappaB ligand and osteoprotegerin: regulators of bone physiology and immune responses\/potential therapeutic agents and biochemical markers","volume":"39","author":"Buckley","year":"2002","journal-title":"Ann. Clin. Biochem."},{"issue":"Suppl. 3","key":"10.1016\/j.ejphar.2026.178611_bib32","doi-asserted-by":"crossref","first-page":"49s","DOI":"10.2967\/jnumed.115.170126","article-title":"Evaluation of prostate cancer with 11C-choline PET\/CT for treatment planning, response assessment, and prognosis","volume":"57","author":"Ceci","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"11","key":"10.1016\/j.ejphar.2026.178611_bib33","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41419-020-03175-5","article-title":"Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy","volume":"11","author":"Cerezo","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/21623945.2019.1643189","article-title":"Roles of omental and bone marrow adipocytes in tumor biology","volume":"8","author":"Cha","year":"2019","journal-title":"Adipocyte"},{"issue":"9","key":"10.1016\/j.ejphar.2026.178611_bib35","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/eji.200838289","article-title":"Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells","volume":"38","author":"Cham","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178611_bib36","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.ejphar.2026.178611_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413435","article-title":"Targeting mitochondrial OXPHOS and their regulatory signals in prostate cancers","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib38","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.7150\/thno.40489","article-title":"SREBP1 siRNA enhance the docetaxel effect based on a bone-cancer dual-targeting biomimetic nanosystem against bone metastatic castration-resistant prostate cancer","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"issue":"16","key":"10.1016\/j.ejphar.2026.178611_bib39","doi-asserted-by":"crossref","first-page":"8488","DOI":"10.7150\/thno.114534","article-title":"PTEN restoration and CXCR2 depletion synergistically enhance the effect of enzalutamide and inhibit bone metastatic CRPC","volume":"15","author":"Chen","year":"2025","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.ejphar.2026.178611_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202412244","article-title":"Combined blockade of lipid uptake and synthesis by CD36 inhibitor and SCD1 siRNA is beneficial for the treatment of refractory prostate cancer","volume":"12","author":"Chen","year":"2025","journal-title":"Adv Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2024.100530","article-title":"MicroRNA-335 inhibits invasion and metastasis of prostate cancer by inhibiting glutamine metabolism pathway","volume":"392","author":"Chen","year":"2025","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejphar.2026.178611_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fonc.2013.00329","article-title":"Effects of RANKL-targeted therapy in immunity and cancer","volume":"3","author":"Cheng","year":"2014","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib43","first-page":"143","article-title":"Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer","volume":"4","author":"Chetta","year":"2021","journal-title":"Cancer Drug Resist"},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib44","article-title":"Targeting the triad: phenotypic plasticity, tumor microenvironment and bone microenvironment in prostate cancer bone-metastatic events","volume":"1880","author":"Chi-Cheng","year":"2025","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib45","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1054\/bjoc.2000.1261","article-title":"Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption","volume":"83","author":"Chiao","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2026.178611_bib46","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3389\/fendo.2018.00807","article-title":"Cholesterol and its metabolites in tumor growth: therapeutic potential of statins in cancer treatment","volume":"9","author":"Chimento","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib47","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1152\/physrev.00012.2019","article-title":"Bone metastasis: mechanisms, therapies, and biomarkers","volume":"101","author":"Cl\u00e9zardin","year":"2021","journal-title":"Physiol. Rev."},{"issue":"7519","key":"10.1016\/j.ejphar.2026.178611_bib48","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.ejphar.2026.178611_bib49","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1200\/JCO.2005.06.091","article-title":"Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid","volume":"23","author":"Coleman","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.clgc.2013.04.009","article-title":"Metabolic syndrome as a peculiar target for management of prostate cancer patients","volume":"11","author":"Conteduca","year":"2013","journal-title":"Clin. Genitourin. Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0090-4295(97)00124-6","article-title":"Citrate metabolism of normal and malignant prostate epithelial cells","volume":"50","author":"Costello","year":"1997","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1097-0045(19980601)35:4<285::AID-PROS8>3.0.CO;2-F","article-title":"Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer","volume":"35","author":"Costello","year":"1998","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000012183","article-title":"The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy","volume":"59","author":"Costello","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.ejphar.2026.178611_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbo.2017.09.001","article-title":"The role of biomarkers in the management of bone-homing malignancies","volume":"9","author":"D'Oronzo","year":"2017","journal-title":"J. Bone Oncol."},{"issue":"19","key":"10.1016\/j.ejphar.2026.178611_bib55","doi-asserted-by":"crossref","first-page":"9781","DOI":"10.3390\/ijms26199781","article-title":"Adipocyte\u2013tumor interactions in the bone marrow niche: implications for metastasis and therapy","volume":"26","author":"Dabaliz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.ejphar.2026.178611_bib56","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/0008-5472.CAN-07-6541","article-title":"Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms","volume":"68","author":"Dai","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.178611_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2407-14-52","article-title":"Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells","volume":"14","author":"Demir","year":"2014","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.ejphar.2026.178611_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.07.068","article-title":"Re-education of tumor-associated macrophages by CXCR2 blockade drives senescence and tumor inhibition in advanced prostate cancer","volume":"28","author":"Di Mitri","year":"2019","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib59","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/cncr.20056","article-title":"Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies","volume":"100","author":"Diamond","year":"2004","journal-title":"Cancer"},{"issue":"40","key":"10.1016\/j.ejphar.2026.178611_bib60","doi-asserted-by":"crossref","first-page":"64854","DOI":"10.18632\/oncotarget.11712","article-title":"Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1\u03b1 activation","volume":"7","author":"Diedrich","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11914-018-0453-9","article-title":"The lipid side of bone marrow adipocytes: how tumor cells adapt and survive in bone","volume":"16","author":"Diedrich","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"issue":"11","key":"10.1016\/j.ejphar.2026.178611_bib62","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41574-019-0246-y","article-title":"The role of osteoblasts in energy homeostasis","volume":"15","author":"Dirckx","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.178611_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fonc.2019.00219","article-title":"Interactions in the (pre)metastatic niche support metastasis formation","volume":"9","author":"Doglioni","year":"2019","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.ejphar.2026.178611_bib64","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.3390\/ijms22084120","article-title":"Glucose metabolism in osteoblasts in healthy and pathophysiological conditions","volume":"22","author":"Donat","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178611_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1396192","article-title":"Insulin-like growth factor family and prostate cancer: new insights and emerging opportunities","volume":"15","author":"Elemam","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","article-title":"Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism","volume":"3","author":"Elia","year":"2021","journal-title":"Nat. Metab."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib67","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.plipres.2013.08.004","article-title":"Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma","volume":"52","author":"Elsherbiny","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"10","key":"10.1016\/j.ejphar.2026.178611_bib68","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziae091","article-title":"Sclerotic prostate cancer bone metastasis: woven bone lesions with a twist","volume":"8","author":"Eltit","year":"2024","journal-title":"JBMR Plus"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib69","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11914-014-0235-y","article-title":"Aerobic glycolysis in osteoblasts","volume":"12","author":"Esen","year":"2014","journal-title":"Curr. Osteoporos. Rep."},{"issue":"7503","key":"10.1016\/j.ejphar.2026.178611_bib70","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib71","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s11427-019-1735-4","article-title":"Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy","volume":"64","author":"Fan","year":"2021","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib72","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-4165(66)90172-3","article-title":"Testosterone stimulation of citric acid synthesis in the rat prostate","volume":"117","author":"Farnsworth","year":"1966","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib73","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","article-title":"Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism","volume":"142","author":"Ferron","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.178611_bib74","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejmech.2017.07.022","article-title":"Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review","volume":"138","author":"Floresta","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178611_bib75","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1158\/1535-7163.MCT-09-1064","article-title":"Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice","volume":"9","author":"Fritz","year":"2010","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib76","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/jcm8020201","article-title":"Obesity, inflammation, and prostate cancer","volume":"8","author":"Fujita","year":"2019","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib77","first-page":"903","article-title":"Differential expression of osteocalcin during the metastatic progression of prostate cancer","volume":"21","author":"Gardner","year":"2009","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib78","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00216-006-1093-y","article-title":"Biomolecular profiling of metastatic prostate cancer cells in bone marrow tissue using FTIR microspectroscopy: a pilot study","volume":"387","author":"Gazi","year":"2007","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ejphar.2026.178611_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.682911","article-title":"Cholesterol metabolic reprogramming in cancer and its pharmacological modulation as therapeutic strategy","volume":"11","author":"Giacomini","year":"2021","journal-title":"Front. Oncol."},{"issue":"27","key":"10.1016\/j.ejphar.2026.178611_bib80","doi-asserted-by":"crossref","first-page":"24061","DOI":"10.18632\/oncotarget.4448","article-title":"Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread","volume":"6","author":"Giannoni","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107848","article-title":"Metabolic modulation of immunity: a new concept in cancer immunotherapy","volume":"32","author":"Guerra","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2026.178611_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbo.2017.03.001","article-title":"Management of aromatase inhibitor-associated bone loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG","volume":"7","author":"Hadji","year":"2017","journal-title":"J. Bone Oncol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib83","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10585-013-9626-1","article-title":"Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies","volume":"31","author":"Hagberg Thulin","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib84","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10585-015-9714-5","article-title":"Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer","volume":"32","author":"Hardaway","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.ejphar.2026.178611_bib85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2018.03.012","article-title":"Fat-bone interaction within the bone marrow milieu: impact on hematopoiesis and systemic energy metabolism","volume":"119","author":"Hawkes","year":"2019","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib86","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/er.2002-0032","article-title":"Androgen receptor in prostate cancer","volume":"25","author":"Heinlein","year":"2004","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib87","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10555-022-10042-6","article-title":"The role of bone marrow adipocytes in cancer progression: the impact of obesity","volume":"41","author":"Hernandez","year":"2022","journal-title":"Cancer Metastasis Rev."},{"issue":"11","key":"10.1016\/j.ejphar.2026.178611_bib88","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3390\/nu15112536","article-title":"Improving the antitumor effect of chemotherapy with Ocoxin as a novel adjuvant agent to treat prostate cancer","volume":"15","author":"Hernandez-Unzueta","year":"2023","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.ejphar.2026.178611_bib89","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.18632\/oncotarget.1482","article-title":"Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms","volume":"4","author":"Herroon","year":"2013","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41416-019-0644-x","article-title":"Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells","volume":"122","author":"Hu","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.ejphar.2026.178611_bib91","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/jbmr.4091","article-title":"The amino acid sensor Eif2ak4\/GCN2 is required for proliferation of osteoblast progenitors in mice","volume":"35","author":"Hu","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib92","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib93","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12916-023-02763-4","article-title":"Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer","volume":"21","author":"Huang","year":"2023","journal-title":"BMC Med."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib94","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib95","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2265.2005.02339.x","article-title":"Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis","volume":"63","author":"Isidori","year":"2005","journal-title":"Clin. Endocrinol."},{"issue":"18","key":"10.1016\/j.ejphar.2026.178611_bib96","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1158\/1078-0432.CCR-21-0480","article-title":"Adjuvant low-dose statin use after radical prostatectomy: the PRO-STAT randomized clinical trial","volume":"27","author":"Jeong","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.ejphar.2026.178611_bib97","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s13238-014-0082-8","article-title":"Regulation of the pentose phosphate pathway in cancer","volume":"5","author":"Jiang","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.ejphar.2026.178611_bib98","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-030-65768-0_13","article-title":"Metabolism of immune cells in the tumor microenvironment","volume":"1311","author":"Jung","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2026.178611_bib99","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-030-65768-0_15","article-title":"Targeting metabolic cross talk between cancer cells and cancer-associated fibroblasts","volume":"1311","author":"Jung","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib100","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ijc.20314","article-title":"Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications","volume":"111","author":"Jung","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib101","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/and.12237","article-title":"Dutasteride in men receiving testosterone therapy: a randomised, double-blind study","volume":"47","author":"Kacker","year":"2015","journal-title":"Andrologia"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib102","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0090-4295(02)02411-1","article-title":"Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy","volume":"61","author":"Kane","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2026.178611_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1383304","article-title":"Identification of anoikis-related gene signatures and construction of the prognosis model in prostate cancer","volume":"15","author":"Kang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib104","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.eururo.2015.12.005","article-title":"Testosterone therapy in men with prostate cancer","volume":"69","author":"Kaplan","year":"2016","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib105","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/2211-5463.12031","article-title":"High expression of fatty acid-binding protein 5 promotes cell growth and metastatic potential of colorectal cancer cells","volume":"6","author":"Kawaguchi","year":"2016","journal-title":"FEBS Open Bio"},{"issue":"9","key":"10.1016\/j.ejphar.2026.178611_bib106","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6603051","article-title":"Adiponectin and cancer: a systematic review","volume":"94","author":"Kelesidis","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.ejphar.2026.178611_bib107","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","article-title":"Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment","volume":"39","author":"Kfoury","year":"2021","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.ejphar.2026.178611_bib108","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10585-018-9941-7","article-title":"Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival","volume":"35","author":"Khadge","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib109","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0090-4295(00)00895-5","article-title":"Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancer","volume":"57","author":"Kiratli","year":"2001","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.08.018","article-title":"Mitochondrial priming by CD28","volume":"171","author":"Klein Geltink","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib111","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1124\/jpet.110.174870","article-title":"Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression","volume":"336","author":"Kochuparambil","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib112","first-page":"148","article-title":"Androgen and bone mass in men","volume":"5","author":"Kung","year":"2003","journal-title":"Asian J. Androl."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib113","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.cmet.2019.07.014","article-title":"Cell clustering promotes a metabolic switch that supports metastatic colonization","volume":"30","author":"Labuschagne","year":"2019","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.ejphar.2026.178611_bib114","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis","volume":"16","author":"LeBleu","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.apsb.2012.06.008","article-title":"Adiponectin and lipid metabolism in skeletal muscle","volume":"2","author":"Lee","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib116","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/er.2017-00064","article-title":"Energy metabolism of the osteoblast: implications for osteoporosis","volume":"38","author":"Lee","year":"2017","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib117","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.immuni.2020.08.012","article-title":"Systemic immunometabolism: challenges and opportunities","volume":"53","author":"Lercher","year":"2020","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib118","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.devcel.2020.06.018","article-title":"Cancer cells don't live alone: metabolic communication within tumor microenvironments","volume":"54","author":"Li","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejphar.2026.178611_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106584","article-title":"The circHMGCS1-miR-205-5p-ErBB3 axis mediated the Sanggenon C-induced anti-proliferation effects on human prostate cancer","volume":"187","author":"Li","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"39","key":"10.1016\/j.ejphar.2026.178611_bib120","doi-asserted-by":"crossref","first-page":"65143","DOI":"10.18632\/oncotarget.17821","article-title":"CD44 regulates prostate cancer proliferation, invasion and migration via PDK1 and PFKFB4","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2026.178611_bib121","article-title":"Distinct metabolism of bone marrow adipocytes and their role in bone metastasis","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ejphar.2026.178611_bib122","article-title":"Lipolysis of bone marrow adipocytes is required to fuel bone and the marrow niche during energy deficits","volume":"11","author":"Li","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.ejphar.2026.178611_bib123","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8970173","article-title":"Immune checkpoint inhibitor therapy for bone metastases: specific microenvironment and current situation","volume":"2021","author":"Liu","year":"2021","journal-title":"J. Immunol. Res."},{"issue":"13","key":"10.1016\/j.ejphar.2026.178611_bib124","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1021\/jm070219p","article-title":"Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors","volume":"50","author":"Liu","year":"2007","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrc1528","article-title":"Osteoblasts in prostate cancer metastasis to bone","volume":"5","author":"Logothetis","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib126","first-page":"1221","article-title":"FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K\/AKT signaling pathway","volume":"54","author":"Lv","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12858","article-title":"Immunometabolism: from basic mechanisms to translation","volume":"295","author":"Makowski","year":"2020","journal-title":"Immunol. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2026.178611_bib129","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000474903","article-title":"Serum osteocalcin in monitoring bone metastases in advanced prostatic cancer","volume":"21","author":"Marcellini","year":"1992","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178611_bib130","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.eururo.2014.05.012","article-title":"Metformin to prevent prostate cancer: a call to unite","volume":"66","author":"Margel","year":"2014","journal-title":"Eur. Urol."},{"issue":"9","key":"10.1016\/j.ejphar.2026.178611_bib131","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/cells13090724","article-title":"Bone marrow adipose tissue","volume":"13","author":"Marinelli Busilacchi","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib132","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2049-3002-2-3","article-title":"Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways","volume":"2","author":"Masson","year":"2014","journal-title":"Cancer Metab"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib133","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/cancers12041014","article-title":"Contribution of macrophages and T cells in skeletal metastasis","volume":"12","author":"Mendoza-Reinoso","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib134","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/biom15030331","article-title":"Research progress on the influence of novel targeted drugs for osteoporosis on glucose metabolism","volume":"15","author":"Meng","year":"2025","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib135","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/pros.21063","article-title":"Ras responsive element binding protein-1 (RREB-1) down-regulates hZIP1 expression in prostate cancer cells","volume":"70","author":"Milon","year":"2010","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib136","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jcmm.12004","article-title":"Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells","volume":"17","author":"Mimeault","year":"2013","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2026.178611_bib137","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fonc.2018.00081","article-title":"Metabolic symbiosis and immunomodulation: how tumor cell-derived lactate may disturb innate and adaptive immune responses","volume":"8","author":"Morrot","year":"2018","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib138","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5604\/01.3001.0054.9875","article-title":"The role of citrate in formation of mineral structure of bone","volume":"26","author":"Moskalewski","year":"2024","journal-title":"Ortop. Traumatol. Rehabil."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib139","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10555-022-10059-x","article-title":"The adipocyte microenvironment and cancer","volume":"41","author":"Mukherjee","year":"2022","journal-title":"Cancer Metastasis Rev."},{"issue":"11","key":"10.1016\/j.ejphar.2026.178611_bib140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrurol.2017.144","article-title":"WNT signalling in prostate cancer","volume":"14","author":"Murillo-Garz\u00f3n","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ejphar.2026.178611_bib141","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-030-65768-0_11","article-title":"The intratumoral heterogeneity of cancer metabolism","volume":"1311","author":"Nabi","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib142","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11914-010-0011-6","article-title":"Tumor-stromal interactions in bone metastasis","volume":"8","author":"Nannuru","year":"2010","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.ejphar.2026.178611_bib143","doi-asserted-by":"crossref","DOI":"10.1038\/srep18669","article-title":"Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers","volume":"6","author":"Nath","year":"2016","journal-title":"Sci. Rep."},{"issue":"198","key":"10.1016\/j.ejphar.2026.178611_bib144","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006070","article-title":"Metabolic imaging of patients with prostate cancer using hyperpolarized [1-13C]pyruvate","volume":"5","author":"Nelson","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"16","key":"10.1016\/j.ejphar.2026.178611_bib145","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1158\/0008-5472.CAN-19-0617","article-title":"Microenvironmental metabolism regulates antitumor immunity","volume":"79","author":"Ngwa","year":"2019","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib146","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/15384101.2022.2123187","article-title":"Mechanistic target of rapamycin (mTOR) regulates self-sustained quiescence, tumor indolence, and late clinical metastasis in a Beclin-1-dependent manner","volume":"22","author":"Nicco","year":"2023","journal-title":"Cell Cycle"},{"issue":"10","key":"10.1016\/j.ejphar.2026.178611_bib147","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbalip.2013.02.010","article-title":"Adipose tissue and adipocytes support tumorigenesis and metastasis","volume":"1831","author":"Nieman","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.ejphar.2026.178611_bib148","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1464-410X.2011.10555.x","article-title":"A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy","volume":"109","author":"Nobes","year":"2012","journal-title":"BJU Int."},{"issue":"9","key":"10.1016\/j.ejphar.2026.178611_bib149","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"Pt 3","key":"10.1016\/j.ejphar.2026.178611_bib150","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2026.178611_bib151","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Rev."},{"issue":"27","key":"10.1016\/j.ejphar.2026.178611_bib152","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1038\/s41388-021-01874-7","article-title":"Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone","volume":"40","author":"Pan","year":"2021","journal-title":"Oncogene"},{"issue":"7635","key":"10.1016\/j.ejphar.2026.178611_bib153","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib154","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.ejphar.2026.178611_bib155","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1080\/15384101.2023.2206502","article-title":"Basal epithelial cells in prostate development, tumorigenesis, and cancer progression","volume":"22","author":"Pitzen","year":"2023","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.ejphar.2026.178611_bib156","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/ijc.23715","article-title":"Association between plasma cholesterol and prostate cancer in the PSA era","volume":"123","author":"Platz","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib157","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1194\/jlr.S091793","article-title":"Adipokine FABP4 integrates energy stores and counterregulatory metabolic responses","volume":"60","author":"Prentice","year":"2019","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178611_bib158","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.eururo.2014.04.027","article-title":"Metformin use and prostate cancer risk","volume":"66","author":"Preston","year":"2014","journal-title":"Eur. Urol."},{"issue":"8","key":"10.1016\/j.ejphar.2026.178611_bib159","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41416-024-02762-z","article-title":"Metabolic adaptations in prostate cancer","volume":"131","author":"Pujana-Vaquerizo","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2026.178611_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1333284","article-title":"Positive correlation between the nuclear expression of GPER and pGLI3 in prostate cancer tissues from patients with different Gleason scores","volume":"15","author":"Rico-Fuentes","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib161","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/cancers10020056","article-title":"Cancer stem cells, bone and tumor microenvironment: key players in bone metastasis","volume":"10","author":"Roato","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.178611_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1481241","article-title":"The skeleton: an overlooked regulator of systemic glucose metabolism in cancer?","volume":"14","author":"Ronghe","year":"2024","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib163","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1022627421000","article-title":"Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results","volume":"20","author":"Roudier","year":"2003","journal-title":"Clin. Exp. Metastasis"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib164","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.juro.2008.04.140","article-title":"Histopathological assessment of prostate cancer bone osteoblastic metastases","volume":"180","author":"Roudier","year":"2008","journal-title":"J. Urol."},{"issue":"9","key":"10.1016\/j.ejphar.2026.178611_bib165","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.3390\/ijms25094762","article-title":"CYP7B1 as a biomarker for prostate cancer risk and progression: metabolic and oncogenic signatures (diagnostic immunohistochemistry analysis by tissue microarray in prostate cancer patients-Diamond study)","volume":"25","author":"Russo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178611_bib166","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.urology.2004.12.053","article-title":"Prostate cancer and adiponectin","volume":"65","author":"S Goktas","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2026.178611_bib167","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2407-14-154","article-title":"Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression","volume":"14","author":"Sanit\u00e0","year":"2014","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.ejphar.2026.178611_bib168","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1158\/1535-7163.MCT-14-0183","article-title":"Lipid catabolism via CPT1 as a therapeutic target for prostate cancer","volume":"13","author":"Schlaepfer","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib169","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41467-020-15237-5","article-title":"OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation","volume":"11","author":"Sch\u00f6pf","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178611_bib170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2490-10-9","article-title":"A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma","volume":"10","author":"Serpa Neto","year":"2010","journal-title":"BMC Urol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib171","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40364-024-00588-8","article-title":"Lipid metabolism in tumor-infiltrating regulatory T cells: perspective to precision immunotherapy","volume":"12","author":"Shan","year":"2024","journal-title":"Biomark. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib172","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.31313","article-title":"Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer","volume":"143","author":"Shao","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2026.178611_bib173","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.71595","article-title":"SLC1A5 provides glutamine and asparagine necessary for bone development in mice","volume":"10","author":"Sharma","year":"2021","journal-title":"eLife"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib174","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/jcm10030530","article-title":"Testosterone and bone health in men: a narrative review","volume":"10","author":"Shigehara","year":"2021","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/10915360050138620","article-title":"Tissue-specific promoters in gene therapy for the treatment of prostate cancer","volume":"4","author":"Shirakawa","year":"2000","journal-title":"Mol. Urol."},{"issue":"17","key":"10.1016\/j.ejphar.2026.178611_bib176","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.3390\/cancers14174293","article-title":"Role of lipids and lipid metabolism in prostate cancer progression and the tumor's immune environment","volume":"14","author":"Siltari","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.ejphar.2026.178611_bib177","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41574-024-00969-x","article-title":"Metabolic regulation of skeletal cell fate and function","volume":"20","author":"Stegen","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.178611_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.680928","article-title":"Expression and clinical significance of HKII and HIF-1\u03b1 in grade groups of prostate cancer","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Genet."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib179","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib180","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.semnuclmed.2023.06.005","article-title":"Role of FDG PET\/CT in management of patients with prostate cancer","volume":"54","author":"Sutherland","year":"2024","journal-title":"Semin. Nucl. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib181","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/1097-0215(20001015)88:2<176::AID-IJC5>3.0.CO;2-3","article-title":"Selective activation of the fatty acid synthesis pathway in human prostate cancer","volume":"88","author":"Swinnen","year":"2000","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib182","article-title":"Mitochondria: the metabolic switch of cellular oncogenic transformation","volume":"1876","author":"Tan","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"16","key":"10.1016\/j.ejphar.2026.178611_bib183","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/pros.21029","article-title":"Adiponectin increases motility of human prostate cancer cells via AdipoR, p38, AMPK, and NF-kappaB pathways","volume":"69","author":"Tang","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.ejphar.2026.178611_bib184","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3389\/fimmu.2019.02278","article-title":"NK cell metabolism and tumor microenvironment","volume":"10","author":"Terren","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178611_bib185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","article-title":"The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling","volume":"15","author":"Theoleyre","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"issue":"12","key":"10.1016\/j.ejphar.2026.178611_bib186","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014175","article-title":"Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol","volume":"5","author":"Thysell","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ejphar.2026.178611_bib187","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1464-410X.2003.04218.x","article-title":"Prostate cancer cell growth is modulated by adipocyte-cancer cell interaction","volume":"91","author":"Tokuda","year":"2003","journal-title":"BJU Int."},{"issue":"1.2","key":"10.1016\/j.ejphar.2026.178611_bib188","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2152\/jmi.65.9","article-title":"Adipose tissue: critical contributor to the development of prostate cancer","volume":"65","author":"Uehara","year":"2018","journal-title":"J. Med. Investig."},{"issue":"11","key":"10.1016\/j.ejphar.2026.178611_bib189","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.biocel.2012.08.013","article-title":"Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile","volume":"44","author":"Vaz","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib190","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1464-410X.2006.06670.x","article-title":"Bone and prostate cancer cell interactions in metastatic prostate cancer","volume":"99","author":"Vela","year":"2007","journal-title":"BJU Int."},{"issue":"12","key":"10.1016\/j.ejphar.2026.178611_bib191","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1158\/1055-9965.EPI-14-0795","article-title":"Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study","volume":"23","author":"Vidal","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178611_bib192","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ncb3365","article-title":"PGC1alpha drives a metabolic block on prostate cancer progression","volume":"18","author":"Wallace","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib193","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2003-032006","article-title":"Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men","volume":"89","author":"Wang","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2026.178611_bib194","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2020.05.007","article-title":"GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers","volume":"485","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"issue":"24","key":"10.1016\/j.ejphar.2026.178611_bib195","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1158\/0008-5472.CAN-11-1821","article-title":"Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression","volume":"71","author":"Wang","year":"2011","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.ejphar.2026.178611_bib196","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/jnci\/djt241","article-title":"Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development","volume":"105","author":"Wang","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178611_bib197","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/path.4518","article-title":"Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development","volume":"236","author":"Wang","year":"2015","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.ejphar.2026.178611_bib198","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/pros.23000","article-title":"Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor","volume":"75","author":"Wang","year":"2015","journal-title":"Prostate"},{"issue":"478","key":"10.1016\/j.ejphar.2026.178611_bib199","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5758","article-title":"Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer","volume":"11","author":"Watt","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.ejphar.2026.178611_bib200","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf9096","article-title":"Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival","volume":"8","author":"Whitburn","year":"2022","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib201","first-page":"49","article-title":"RANKL\/RANK\/OPG: new therapeutic targets in bone tumours and associated osteolysis","volume":"1704","author":"Wittrant","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.ejphar.2026.178611_bib202","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.fertnstert.2011.08.010","article-title":"Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells","volume":"96","author":"Wong","year":"2011","journal-title":"Fertil. Steril."},{"issue":"10","key":"10.1016\/j.ejphar.2026.178611_bib203","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.3390\/ijms20102587","article-title":"Prostate cancer and bone metastases: the underlying mechanisms","volume":"20","author":"Wong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.ejphar.2026.178611_bib204","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/metabo11110765","article-title":"Fatty acid metabolism reprogramming in advanced prostate cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib205","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bbrc.2019.11.080","article-title":"High glucose inhibits proliferation and differentiation of osteoblast in alveolar bone by inducing pyroptosis","volume":"522","author":"Yang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib206","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/13685538.2018.1524456","article-title":"Testosterone, testosterone therapy and prostate cancer","volume":"22","author":"Yassin","year":"2019","journal-title":"Aging Male"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib207","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00774-020-01175-1","article-title":"Discovery of the RANKL\/RANK\/OPG system","volume":"39","author":"Yasuda","year":"2021","journal-title":"J Bone Miner Metab"},{"issue":"19","key":"10.1016\/j.ejphar.2026.178611_bib208","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.1830978100","article-title":"A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases","volume":"100","author":"Yin","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.ejphar.2026.178611_bib209","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic reprogramming: the emerging concept and associated therapeutic strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.ejphar.2026.178611_bib210","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.nucmedbio.2004.05.002","article-title":"Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate","volume":"31","author":"Yoshimoto","year":"2004","journal-title":"Nucl. Med. Biol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178611_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.01.016","article-title":"Glutamine metabolism regulates proliferation and lineage allocation in skeletal stem cells","volume":"29","author":"Yu","year":"2019","journal-title":"Cell Metab."},{"issue":"23","key":"10.1016\/j.ejphar.2026.178611_bib212","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.3390\/cells12232695","article-title":"Effects of Dickkopf-1 (DKK-1) on prostate cancer growth and bone metastasis","volume":"12","author":"Yuan","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib213","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1073\/pnas.1808834116","article-title":"Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer","volume":"116","author":"Zadra","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"10.1016\/j.ejphar.2026.178611_bib214","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.cell.2021.03.011","article-title":"The bone microenvironment invigorates metastatic seeds for further dissemination","volume":"184","author":"Zhang","year":"2021","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178611_bib215","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4161\/onci.1.2.18480","article-title":"Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer","volume":"1","author":"Zhao","year":"2012","journal-title":"OncoImmunology"},{"issue":"22","key":"10.1016\/j.ejphar.2026.178611_bib216","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178611_bib217","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12514","article-title":"Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1","volume":"52","author":"Zhou","year":"2019","journal-title":"Cell Prolif."},{"issue":"14","key":"10.1016\/j.ejphar.2026.178611_bib218","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.3390\/cancers16142503","article-title":"ENO2, a glycolytic enzyme, contributes to prostate cancer metastasis: a systematic review of literature","volume":"16","author":"Zhou","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"22","key":"10.1016\/j.ejphar.2026.178611_bib219","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1158\/0008-5472.CAN-04-1987","article-title":"Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12\/CXCR4 signals","volume":"64","author":"Zou","year":"2004","journal-title":"Cancer Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:04:50Z","timestamp":1772456690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926000932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":219,"alternative-id":["S0014299926000932"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178611","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic crosstalk in the metastatic prostate cancer-bone microenvironment: mechanism, detection and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178611"}}